Valuation: Progyny, Inc.

Market Cap 2.06B 1.8B 1.69B 1.54B 2.89B 197B 2.89B 20.27B 7.81B 101B 7.74B 7.57B 325B P/E 2026 *
20.9x
P/E 2027 * 17.7x
Enterprise Value 1.89B 1.65B 1.55B 1.42B 2.65B 181B 2.66B 18.62B 7.18B 92.39B 7.11B 6.95B 298B EV / Sales 2026 *
1.38x
EV / Sales 2027 * 1.13x
Free-Float
75.41%
Yield 2026 *
-
Yield 2027 * -
1 day-1.00%
1 week-3.55%
Current month+4.96%
1 month+4.72%
3 months+2.99%
6 months+48.15%
Current year+4.60%
1 week 26.67
Extreme 26.67
27.92
1 month 25.34
Extreme 25.34
27.98
Current year 16.1
Extreme 16.1
33.06
1 year 16.1
Extreme 16.1
33.06
3 years 13.39
Extreme 13.39
42.08
5 years 13.39
Extreme 13.39
68.32
10 years 13.29
Extreme 13.29
68.32
Manager TitleAgeSince
Chief Executive Officer 58 2021-12-31
Director of Finance/CFO 60 2020-09-14
Chief Operating Officer 56 2025-04-16
Director TitleAgeSince
Chairman 66 2021-12-31
Director/Board Member 77 2016-12-15
Director/Board Member 58 2021-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/10/26 Exercice

Director

66,000 0.0860%
9/10/26 Exercice

Director

-22,000 0.0287%
9/4/26 Tax

General Counsel

-479 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
-1.00%-3.55%+24.24%-19.22% 2.08B
+0.18%-1.56%+12.14%-24.66% 338B
-0.40%-3.52%+30.47%-9.21% 89.12B
-0.29%-5.37%-5.47%-5.63% 72.74B
-1.98%-6.99%+49.84%-23.37% 46.38B
-0.18%-6.37%+104.56%-6.54% 32.16B
-1.49%-7.60%+12.94%-40.91% 10.46B
+1.79%-10.98%+49.83%+320.37% 2.37B
-0.24%-35.63%-49.64%+26.02% 1.73B
Average -0.53%-6.20%+25.43%+24.09% 66.15B
Weighted average by Cap. -0.82%-1.56%+20.69%-17.69%

Financials

2026 *2027 *
Net sales 1.37B 1.2B 1.13B 1.03B 1.93B 132B 1.93B 13.52B 5.21B 67.08B 5.16B 5.05B 216B 1.51B 1.32B 1.24B 1.13B 2.12B 145B 2.12B 14.87B 5.73B 73.8B 5.68B 5.55B 238B
Net income 106M 92.66M 87.27M 79.48M 149M 10.18B 149M 1.05B 403M 5.19B 399M 390M 16.74B 125M 109M 103M 93.74M 176M 12.01B 176M 1.23B 475M 6.12B 471M 460M 19.74B
Net Debt -168M -146M -138M -125M -235M -16.06B -235M -1.65B -635M -8.18B -630M -616M -26.4B -358M -312M -294M -268M -502M -34.29B -502M -3.52B -1.36B -17.47B -1.34B -1.31B -56.36B
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
846
Date Price Change Volume
26-09-21 US$26.86 -1.00% 751,375
26-09-18 US$27.13 +0.44% 3,141,063
26-09-17 US$27.01 -1.35% 828,708
26-09-16 US$27.38 -1.37% 864,466
26-09-15 US$27.76 -0.32% 690,797
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
26.86USD
Average target price
34.42USD
Spread / Average Target
+28.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PGNY Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!